This 2022 narrative review explores the phenomenon of acquired G6PD deficiency, a condition where G6PD enzyme activity is reduced due to non-genetic factors. Unlike the hereditary form, acquired G6PD deficiency arises from biochemical mechanisms that inhibit the enzyme in specific clinical contexts. The review identifies conditions such as hyperaldosteronism, diabetes,
